市場調査レポート
商品コード
1403432

プレフィルドシリンジ市場の2030年までの予測:タイプ別、材料別、設計別、流通チャネル別、用途別、地域別の世界分析

Prefilled Syringes Market Forecasts to 2030 - Global Analysis By Type, By Material, Design, Distribution Channel, Application and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
プレフィルドシリンジ市場の2030年までの予測:タイプ別、材料別、設計別、流通チャネル別、用途別、地域別の世界分析
出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、プレフィルドシリンジの世界市場は2023年に81億5,000万米ドルを占め、予測期間中にCAGR 12.9%で成長し、2030年には190億5,000万米ドルに達する見込みです。

プレフィルドシリンジは、あらかじめ計量された量の薬剤が封入され、単回使用注射用に密封・滅菌された、すぐに使用できる医療機器です。バレル、プランジャー、注射針で構成され、薬剤投与における利便性、正確性、安全性を提供します。プレフィルドシリンジは、投与ミスや汚染リスクを減らし、医療手順を合理化することで、ワクチンや生物製剤から慢性疾患管理や救急医療まで、さまざまな治療における多様な医療ニーズに対応しています。

ジュネーブ協会が発表した報告書によると、過去20年間で、GDPに占めるヘルスケアへの世界総支出の割合は約8%からほぼ10%に増加し、年間8兆米ドルに上ると推定されています。

慢性疾患の増加

糖尿病、自己免疫疾患、さまざまな神経疾患などの慢性疾患の発生率が上昇していることが、プレフィルドシリンジ市場を促進しています。これらの疾患は定期的かつ正確な投薬量を必要とするため、プレフィルドシリンジのようなユーザーフレンドリーで正確なドラッグデリバリーシステムに対する需要が高まっています。利便性、投与量の正確さ、汚染や投与ミスのリスクの低減を提供するプレフィルドシリンジは、頻繁な投薬が必要な患者のニーズに対応します。さらに、慢性疾患の有病率が上昇していることから、ヘルスケアプロバイダーは患者のケアとこれらの疾患の管理を強化するために、効率的ですぐに投与できるソリューションを選択する傾向が強まっており、市場の成長軌道が強調されています。

注射量の制限

これらのシリンジは、多くの薬剤に利便性と正確な投与を提供する一方で、多くの場合、注入量が固定されているか制限されています。この制約は、大量投与が必要な特定の薬剤や、投与量が変化する薬剤に影響します。シリンジの容量を超える薬剤については、代替の送達システムを考慮する必要があり、あらゆる種類の薬剤においてプレフィルドシリンジの普遍的な適用性が制限されます。多様な投与量要件への対応におけるこの限界は、特定の治療領域におけるプレフィルドシリンジの普及を抑制し、市場浸透に影響を与えています。

新興市場におけるヘルスケアインフラの拡大

新興市場におけるヘルスケアインフラの拡大は、プレフィルドシリンジ市場にとって大きな機会となります。これらの地域では医療施設の大幅な増加が見られるため、効率的でコスト効率の高いドラッグデリバリーシステムに対する需要が高まっています。さらに、資源が限られた環境での投与と保管を合理化できる可能性がその魅力を高め、新興国全体で急成長するヘルスケアインフラ内での採用と市場拡大を促進しています。

厳しい規制要件と承認プロセス

厳しい規制要件と承認プロセスがプレフィルドシリンジ市場に大きな脅威を与えています。特に材料適合性、製造基準、無菌性保証に関する複雑な規制基準を遵守する必要があるため、製品開発と市場参入に必要な時間とリソースが長期化します。コンプライアンス上の課題は、承認の遅延、開発コストの増加、技術革新の制限につながる可能性があります。こうした厳格な規制は新規参入の障壁となり、市場競争力に影響を与え、市場の成長を妨げます。

COVID-19の影響:

COVID-19パンデミックはプレフィルドシリンジ市場に大きな影響を与えました。世界中でワクチン接種キャンペーンが急務となり、ワクチンを効率的に投与するためのプレフィルドシリンジの需要が高まった。製造業者は、世界のワクチン流通要件を満たすための増産に直面し、サプライチェーン上の課題と原材料をめぐる競合の激化につながった。さらに、厳格な安全対策、規制の適応、および大規模なワクチン接種キャンペーンへの注目が、安全で効率的かつ拡張可能なワクチン送達ソリューションを確保するためのプレフィルドシリンジ技術への革新と投資を加速させました。

予測期間中、ガラスセグメントが最大となる見込み

プレフィルドシリンジでは、ガラスセグメントが最大の市場シェアを確保すると予想されています。ガラスは化学的不活性などの優れた品質を提供し、安定性と幅広い薬剤との適合性を確保します。その透明性は、薬剤の完全性にとって極めて重要な目視検査を容易にします。生物製剤や繊細な製剤の需要が高まる中、湿気やガスに対するガラスのバリア性が好まれています。さらに、薬物相互作用に関する懸念の高まりと正確なドラッグデリバリーの必要性がガラスへの嗜好を高め、プレフィルドシリンジ市場での優位性を確固たるものにしています。

予測期間中、オンラインストアセグメントのCAGRが最も高くなると予想される

ヘルスケアにおけるeコマースの動向の高まりにより、プレフィルドシリンジ市場ではオンラインストア部門が最も高い成長率を示すと予想されます。オンラインプラットフォームは消費者に利便性、アクセシビリティ、幅広い製品群を提供します。デジタル・プラットフォームの導入が進むにつれ、患者やヘルスケア提供者は医療用品をオンラインで簡単に注文できることを好むようになっています。デジタル化への世界のシフトが進み、非接触取引が重視されるようになったことで、プレフィルドシリンジ市場におけるオンラインストアの急成長が予想されます。

最大のシェアを占める地域:

北米は、強固なヘルスケアインフラ、先進医療技術に対する高い認識、注射薬需要の急増により、プレフィルドシリンジ市場において最大のシェアを確保する見通しです。同地域は製薬産業が確立しており、研究開発への多額の投資と相まって、プレフィルドシリンジの主要市場として位置づけられています。さらに、患者中心のドラッグデリバリーへの注目の高まりがプレフィルドシリンジの採用をさらに促進し、北米が市場で優位な地位を占める一因となっています。

CAGRが最も高い地域:

プレフィルドシリンジ市場におけるアジア太平洋地域の堅調な成長は、同地域のヘルスケアインフラの拡大、医薬品への投資の増加、患者の安全性の重視の高まりに起因しています。ヘルスケア支出の増加、患者人口の多さ、高度なヘルスケア技術を推進する政府の取り組みが、プレフィルドシリンジの需要を促進しています。さらに、慢性疾患の急増と相まって、同地域の予防接種プログラムがプレフィルドシリンジの採用を後押ししています。

無料カスタマイズサービス:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかを提供いたします:

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • アプリケーション分析
  • エンドユーザー分析
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のプレフィルドシリンジ市場:タイプ別

  • 使い捨てプレフィルドシリンジ
  • 再利用可能なプレフィルドシリンジ

第6章 世界のプレフィルドシリンジ市場:材料別

  • ガラス
  • プラスチック

第7章 世界のプレフィルドシリンジ市場:設計別

  • シングルチャンバープレフィルドシリンジ
  • デュアルチャンバープレフィルドシリンジ
  • カスタマイズプレフィルドシリンジ

第8章 世界のプレフィルドシリンジ市場:流通チャネル別

  • 小売薬局およびドラッグストア
  • 外来手術センター
  • オンラインストア

第9章 世界のプレフィルドシリンジ市場:用途別

  • アナフィラキシー
  • 糖尿病
  • 腫瘍学
  • 関節リウマチ
  • 血栓症
  • その他の用途

第10章 世界のプレフィルドシリンジ市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第11章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第12章 企業プロファイル

  • BD(Becton, Dickinson and Company)
  • Catalent
  • Daikyo Seiko, Ltd.
  • Gerresheimer
  • Haselmeier GmbH
  • Nemera
  • Nipro Corporation
  • Recipharm
  • SCHOTT AG
  • SHL Group
  • Stevanato Group
  • Terumo Corporation
  • Vaccinex, Inc.
  • Vetter Pharma International GmbH
  • Weigao Group
  • West Pharmaceutical Services, Inc.
  • Wuxi AppTec
  • Ypsomed
図表

List of Tables

  • Table 1 Global Prefilled Syringes Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 4 Global Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 5 Global Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 6 Global Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 7 Global Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 8 Global Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 9 Global Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 10 Global Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 11 Global Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 12 Global Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 13 Global Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 14 Global Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 15 Global Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 16 Global Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 18 Global Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 19 Global Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 20 Global Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 21 Global Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 22 Global Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 23 North America Prefilled Syringes Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 26 North America Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 27 North America Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 28 North America Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 29 North America Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 30 North America Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 31 North America Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 32 North America Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 33 North America Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 34 North America Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 35 North America Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 36 North America Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 37 North America Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 38 North America Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 39 North America Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 40 North America Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 41 North America Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 42 North America Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 43 North America Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 44 North America Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 45 Europe Prefilled Syringes Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 48 Europe Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 49 Europe Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 50 Europe Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 51 Europe Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 52 Europe Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 53 Europe Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 54 Europe Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 55 Europe Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 56 Europe Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 57 Europe Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 58 Europe Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 59 Europe Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 60 Europe Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 61 Europe Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 62 Europe Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 63 Europe Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 64 Europe Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 65 Europe Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 66 Europe Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 67 Asia Pacific Prefilled Syringes Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 70 Asia Pacific Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 71 Asia Pacific Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 72 Asia Pacific Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 73 Asia Pacific Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 74 Asia Pacific Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 75 Asia Pacific Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 76 Asia Pacific Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 77 Asia Pacific Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 78 Asia Pacific Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 79 Asia Pacific Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 80 Asia Pacific Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 81 Asia Pacific Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 82 Asia Pacific Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 83 Asia Pacific Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 84 Asia Pacific Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 85 Asia Pacific Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 86 Asia Pacific Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 87 Asia Pacific Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 88 Asia Pacific Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 89 South America Prefilled Syringes Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 92 South America Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 93 South America Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 94 South America Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 95 South America Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 96 South America Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 97 South America Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 98 South America Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 99 South America Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 100 South America Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 101 South America Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 102 South America Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 103 South America Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 104 South America Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 105 South America Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 106 South America Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 107 South America Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 108 South America Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 109 South America Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 110 South America Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 111 Middle East & Africa Prefilled Syringes Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Prefilled Syringes Market Outlook, By Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Prefilled Syringes Market Outlook, By Disposable Prefilled Syringes (2021-2030) ($MN)
  • Table 114 Middle East & Africa Prefilled Syringes Market Outlook, By Reusable Prefilled Syringes (2021-2030) ($MN)
  • Table 115 Middle East & Africa Prefilled Syringes Market Outlook, By Material (2021-2030) ($MN)
  • Table 116 Middle East & Africa Prefilled Syringes Market Outlook, By Glass (2021-2030) ($MN)
  • Table 117 Middle East & Africa Prefilled Syringes Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 118 Middle East & Africa Prefilled Syringes Market Outlook, By Design (2021-2030) ($MN)
  • Table 119 Middle East & Africa Prefilled Syringes Market Outlook, By Single-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 120 Middle East & Africa Prefilled Syringes Market Outlook, By Dual-Chamber Prefilled Syringes (2021-2030) ($MN)
  • Table 121 Middle East & Africa Prefilled Syringes Market Outlook, By Customized Prefilled Syringes (2021-2030) ($MN)
  • Table 122 Middle East & Africa Prefilled Syringes Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 123 Middle East & Africa Prefilled Syringes Market Outlook, By Retail Pharmacies and Drug Stores (2021-2030) ($MN)
  • Table 124 Middle East & Africa Prefilled Syringes Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 125 Middle East & Africa Prefilled Syringes Market Outlook, By Online Stores (2021-2030) ($MN)
  • Table 126 Middle East & Africa Prefilled Syringes Market Outlook, By Application (2021-2030) ($MN)
  • Table 127 Middle East & Africa Prefilled Syringes Market Outlook, By Anaphylaxis (2021-2030) ($MN)
  • Table 128 Middle East & Africa Prefilled Syringes Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 129 Middle East & Africa Prefilled Syringes Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 130 Middle East & Africa Prefilled Syringes Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
  • Table 131 Middle East & Africa Prefilled Syringes Market Outlook, By Thrombosis (2021-2030) ($MN)
  • Table 132 Middle East & Africa Prefilled Syringes Market Outlook, By Other Applications (2021-2030) ($MN)
目次
Product Code: SMRC24657

According to Stratistics MRC, the Global Prefilled Syringes Market is accounted for $8.15 billion in 2023 and is expected to reach $19.05 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Prefilled syringes are ready-to-use medical devices containing a premeasured dose of medication, sealed and sterilized for single-use injection. Comprising a barrel, plunger and needle, they offer convenience, accuracy, and safety in drug administration. Prefilled syringes reduce dosing errors, contamination risks and streamline medical procedures, catering to diverse healthcare needs across various treatments, from vaccines and biologics to chronic disease management and emergency medicine.

According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The escalating incidence of chronic illnesses, such as diabetes, autoimmune disorders, and various neurological conditions, has propelled the prefilled syringes market. These conditions require regular and precise medication dosages, fostering the demand for user-friendly, accurate drug delivery systems like prefilled syringes. Offering convenience, dosage accuracy and reduced risks of contamination or dosage errors, prefilled syringes address the needs of patients requiring frequent medication. Additionally, this rising prevalence of chronic diseases emphasizes the market's growth trajectory as healthcare providers increasingly opt for efficient, ready-to-administer solutions to enhance patient care and management of these conditions.

Restraint:

Injection volume limitations

These syringes offer convenience and accurate dosing for many medications, they often come with fixed or limited injection volumes. This constraint affects certain drugs requiring larger doses or those with variable dosage needs. For medications that exceed the syringe's volume capacity, alternative delivery systems must be considered, limiting the universal applicability of prefilled syringes across all medication types. This limitation in accommodating diverse dosage requirements restrains their widespread adoption in certain therapeutic areas, impacting their market penetration.

Opportunity:

Growing healthcare infrastructure across emerging markets

The expanding healthcare infrastructure in emerging markets presents a significant opportunity for the prefilled syringes market. As these regions witness substantial growth in medical facilities, there's a heightened demand for efficient and cost-effective drug delivery systems. Additionally, their potential for streamlined administration and storage in resource-limited settings enhances their attractiveness, driving their adoption and market expansion within burgeoning healthcare infrastructures across emerging economies.

Threat:

Stringent regulatory requirements and approval processes

Stringent regulatory requirements and approval processes pose a significant threat to the prefilled syringes market. The need to adhere to complex regulatory standards, especially regarding material compatibility, manufacturing standards and sterility assurance, prolongs the time and resources required for product development and market entry. Compliance challenges may lead to delays in approvals, increasing development costs and potentially limiting innovation. These rigorous regulations create barriers for new entrants, impacting market competitiveness and hindering market growth.

COVID-19 Impact:

The COVID-19 pandemic significantly impacted the prefilled syringes market. The urgent need for vaccination campaigns worldwide propelled demand for prefilled syringes to administer vaccines efficiently. Manufacturers faced increased production to meet global vaccine distribution requirements, leading to supply chain challenges and heightened competition for materials. Additionally, stringent safety measures, regulatory adaptations and the focus on mass vaccination campaigns accelerated innovation and investment in prefilled syringe technologies to ensure safe, efficient and scalable vaccine delivery solutions.

The glass segment is expected to be the largest during the forecast period

The glass segment is anticipated to secure the largest market share in prefilled syringes. Glass offers superior qualities such as chemical inertness, ensuring stability and compatibility with a wide range of medications. Its transparency enables easy visual inspection, which is crucial for drug integrity. With an increasing demand for biologics and sensitive formulations, glass's barrier properties against moisture and gases are preferred. Moreover, heightened concerns about drug interaction and the need for precise drug delivery amplify the preference for glass, solidifying its dominance in the prefilled syringes market.

The online stores segment is expected to have the highest CAGR during the forecast period

The online store segment is expected to witness the highest growth rate in the prefilled syringes market due to the increasing trend of e-commerce in healthcare. Online platforms provide convenience, accessibility, and a wide product range for consumers. With the rising adoption of digital platforms, patients and healthcare providers prefer the ease of ordering medical supplies online. The ongoing global shift towards digitalization and emphasizing contactless transactions further drives the anticipated rapid growth of online stores in the prefilled syringes market.

Region with largest share:

North America is poised to secure the largest market share in prefilled syringes due to a robust healthcare infrastructure, high awareness of advanced medical technologies, and a surge in demand for injectable drugs. The region's well-established pharmaceutical industry, coupled with significant investments in research and development, positions it as a key market for prefilled syringes. Additionally, increased focus on patient-centric drug delivery further fuels the adoption of prefilled syringes, contributing to North America's dominant position in the market.

Region with highest CAGR:

Asia Pacific's robust growth in the prefilled syringes market is attributed to the region's expanding healthcare infrastructure, rising investments in pharmaceuticals and a growing emphasis on patient safety. Increasing healthcare expenditure, a large patient population and government initiatives promoting advanced healthcare technologies drive the demand for prefilled syringes. Moreover, the region's escalating vaccination programs, coupled with the burgeoning prevalence of chronic diseases, bolster the adoption of prefilled syringes.

Key players in the market:

Some of the key players in prefilled syringes market include BD (Becton, Dickinson and Company), Catalent, Daikyo Seiko, Ltd., Gerresheimer, Haselmeier GmbH, Nemera, Nipro Corporation, Recipharm, SCHOTT AG, SHL Group, Stevanato Group, Terumo Corporation, Vaccinex, Inc., Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., Wuxi AppTec and Ypsomed.

Key Developments:

In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60® Infusion System with Hizentra® 50 mL Prefilled Syringes.

In May 2023, Nexus Pharmaceuticals announced the FDA approval of single-dose prefilled syringes for Emerphed® (ephedrine sulfate injection) used for the treatment of clinically important hypotension occurring in the setting of anesthesia.

In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.

Types Covered:

  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes

Materials Covered:

  • Glass
  • Plastic

Designs Covered:

  • Single-Chamber Prefilled Syringes
  • Dual-Chamber Prefilled Syringes
  • Customized Prefilled Syringes

Distribution Channels Covered:

  • Retail Pharmacies and Drug Stores
  • Ambulatory Surgery Centers
  • Online Stores

Applications Covered:

  • Anaphylaxis
  • Diabetes
  • Oncology
  • Rheumatoid Arthritis
  • Thrombosis
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Prefilled Syringes Market, By Type

  • 5.1 Introduction
  • 5.2 Disposable Prefilled Syringes
  • 5.3 Reusable Prefilled Syringes

6 Global Prefilled Syringes Market, By Material

  • 6.1 Introduction
  • 6.2 Glass
  • 6.3 Plastic

7 Global Prefilled Syringes Market, By Design

  • 7.1 Introduction
  • 7.2 Single-Chamber Prefilled Syringes
  • 7.3 Dual-Chamber Prefilled Syringes
  • 7.4 Customized Prefilled Syringes

8 Global Prefilled Syringes Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Pharmacies and Drug Stores
  • 8.3 Ambulatory Surgery Centers
  • 8.4 Online Stores

9 Global Prefilled Syringes Market, By Application

  • 9.1 Introduction
  • 9.2 Anaphylaxis
  • 9.3 Diabetes
  • 9.4 Oncology
  • 9.5 Rheumatoid Arthritis
  • 9.6 Thrombosis
  • 9.7 Other Applications

10 Global Prefilled Syringes Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 BD (Becton, Dickinson and Company)
  • 12.2 Catalent
  • 12.3 Daikyo Seiko, Ltd.
  • 12.4 Gerresheimer
  • 12.5 Haselmeier GmbH
  • 12.6 Nemera
  • 12.7 Nipro Corporation
  • 12.8 Recipharm
  • 12.9 SCHOTT AG
  • 12.10 SHL Group
  • 12.11 Stevanato Group
  • 12.12 Terumo Corporation
  • 12.13 Vaccinex, Inc.
  • 12.14 Vetter Pharma International GmbH
  • 12.15 Weigao Group
  • 12.16 West Pharmaceutical Services, Inc.
  • 12.17 Wuxi AppTec
  • 12.18 Ypsomed